Dr. David Danish Shares Insights on on Leucovorin and Autism in The Epoch Times

In a recent article published by The Epoch Times, Dr. David Danish of Philadelphia Integrative Psychiatry was quoted in discussion of Leucovorin as a potentially promising treatment adjunct for autism. The piece — “Leucovorin Could Be a Promising New Treatment for Autism — Here’s Why” — explores emerging research on folate metabolism, its clinical applications, and how it may influence behavior and cognition in some autistic individuals. The Epoch Times

Dr. Danish offers a clinical perspective on safety, dosing considerations, and practical limitations, emphasizing the importance of patient-specific evaluation and monitoring.

Interested in how this translates to real-world practice, and whether Leucovorin might make sense for certain patients?

Read on for a deeper dive into the science and Dr. Danish’s recommendations.


Back to Blog

Disclaimer: This guide is for informational purposes only and not a substitute for medical advice. Any treatment—whether a supplement, medication, procedure, injection, therapy, or device—carries potential risks, especially when used in excess or by individuals with certain medical conditions or genetic predispositions. Always consult a qualified healthcare provider before starting any treatment.

Previous
Previous

Inflammation, Glutathione, and Autism: Untangling the Complex Web

Next
Next

Dr. Danish Quoted in National Coverage on Leucovorin & Autism